Skip to main content
. 2012 Jan 16;35(2):299–304. doi: 10.2337/dc11-1313

Figure 1.

Figure 1

Adjusted* survival using alternative diabetes-related treatment regimens: monotherapy within 90 days of cancer diagnosis. Note: the patterns of survival in the insulin and sulfonylurea groups are the same. *Cox model specification: age, sex, smoking status, year of cancer diagnosis, and Charlson comorbidity index.